TRAILRUNNER-ALZ 3 (J1G-MC-LAKI)

Name: TRAILRUNNER-ALZ 3 (J1G-MC-LAKI)
Price range: $$

By provision.admin / February 5, 2025

Listing Category

Description

A Study of Remternetug Versus Placebo in Early Alzheimer’s Disease Participants at Risk for Cognitive and Functional Decline

Study Status

Active: Closed to Patient Enrollment

Trial Documentation:

Principal Investigator

Dr. Monica Crane, Tennessee Memory Disorder Foundation